Tema Oncology ETF (CANC) Price, Holdings, & News

ETF Overview

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

Key Stats

• Today's Range: $24.30 to $24.73
• 50-Day Range: $24.31 to $28.81
• 52-Week Range: $24.00 to $30.11
• Volume: 36,311 shs
• Average Volume: 7,025 shs
• Market Capitalization: $42.54 million
• Assets Under Management: $43.43 million
• Dividend Yield: 2.94%
• Net Expense Ratio: 0.75%
• Aggregate Rating: Moderate Buy

CANC ETF - Frequently Asked Questions

How have CANC shares performed this year?

Tema Oncology ETF's stock was trading at $26.40 at the beginning of 2024. Since then, CANC stock has decreased by 7.4% and is now trading at $24.45.
View the best growth stocks for 2024 here.

Who are Tema Oncology ETF's major shareholders?

Top institutional investors of Tema Oncology ETF include Thrivent Financial for Lutherans (22.96%) and Jane Street Group LLC (2.55%).

How do I buy shares of Tema Oncology ETF?

Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Tema Oncology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Oncology ETF investors own include Archer Aviation (ACHR), Advanced Micro Devices (AMD), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Lockheed Martin (LMT), NICE (NICE) and Intellia Therapeutics (NTLA).

Fund Details

• Issuer: Tema Global
• Fund Name: Tema Oncology ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:CANC
• Inception Date: 8/15/2023
• Fund Manager: David Song
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: N/A
• Category: Strategy
• Focus: Theme
• Development Level: Developed Markets
• Region: Global
• Number of Holdings: 50

Fund Statistics

• Assets Under Management: $43.43 million
• Average Daily Volume: $0.00
• Discount/Premium: 0.08%

Administrator, Advisor and Custodian

• Administrator: US Bancorp Fund Services, LLC
• Advisor: Tema Global Limited
• Custodian: U.S. Bank, N.A.
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: U.S. Bancorp Fund Services, LLC
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 2,200 shs

Miscellaneous

• Outstanding Shares: 1,740,000
• Beta: 1.11
• Creation Unit: 10,000
• Creation Fee: $500.00